🇺🇸 Fludarabine Injection in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 9

Most-reported reactions

1. Corneal Epithelium Defect — 1 report (11.11%)
2. Drug Interaction — 1 report (11.11%)
3. Hepatic Encephalopathy — 1 report (11.11%)
4. Lung Infection — 1 report (11.11%)
5. Lung Infiltration — 1 report (11.11%)
6. Optic Neuritis — 1 report (11.11%)
7. Plasma Cell Myeloma — 1 report (11.11%)
8. Thrombotic Microangiopathy — 1 report (11.11%)
9. Vision Blurred — 1 report (11.11%)

Source database →

Frequently asked questions

Is Fludarabine Injection approved in United States?

Fludarabine Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fludarabine Injection in United States?

University of California, San Francisco is the originator. The local marketing authorisation holder may differ — check the official source linked above.